Clinical Trial Update: A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy and safety of VX-150 in osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• VX-150

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED